AVADEL PHARMACEUTICALS PLC·4

Apr 30, 5:51 PM ET

DUBOW JORDAN 4

4 · AVADEL PHARMACEUTICALS PLC · Filed Apr 30, 2019

Insider Transaction Report

Form 4
Period: 2019-04-11
DUBOW JORDAN
Chief Medical Officer
Transactions
  • Award

    Stock Option (right to buy)

    2019-04-11$1.44/sh+340,000$489,600340,000 total
    Exercise: $1.44Exp: 2029-04-11ADSs (340,000 underlying)
Footnotes (2)
  • [F1]Options become exercisable as to 85,000 ADSs on each of the first four anniversaries after the 04/11/2019 grant date.
  • [F2]The issuer's "ADSs" are American Depositary Shares, with each ADS representing one ordinary share, nominal value $0.01 per share, of the issuer; ADSs may be represented by American Depositary Receipts.

Documents

1 file
  • 4
    doc1.xmlPrimary

    FORM 4